SCHEMBL3161815

SCHEMBL3161815

CC(=O)NCCNc1cc(NC(=O)C(=O)N2CCN(C3CCCCCC3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 6/20 0.42
▸ ADORA1 P30542 6/20 0.42
▸ ADORA3 P0DMS8 4/20 0.41
▸ ADORA2B P29275 2/20 0.41
▸ HRH3 Q9Y5N1 1/20 0.40
▸ KDM4E B2RXH2 5/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ ACACB O00763 3/20 0.40
▸ ACACA Q13085 3/20 0.40
▸ POLB P06746 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ KMT2A Q03164 1/20 0.39
▸ MAPT P10636 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ ALOX12 P18054 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3171802 0.99 ADORA2A (0.41) ADORA2AADORA1ADORA3ADORA2BHRH3
SCHEMBL3171546 0.92 ADORA2A (0.40) ADORA2AADORA1ADORA3ADORA2BHRH3
SCHEMBL3174594 0.89 ADORA2A (0.45) ADORA2AADORA1ADORA3ADORA2BKDM4E
SCHEMBL3166225 0.89 ADORA2A (0.45) ADORA2AADORA1ADORA3ADORA2BKDM4E
SCHEMBL3162937 0.88 ADORA2A (0.46) ADORA2AADORA1ADORA3ADORA2BKDM4E
SCHEMBL3175769 0.87 ADORA2A (0.45) ADORA2AADORA1ADORA3ADORA2BKDM4E
SCHEMBL3169774 0.87 ADORA2A (0.43) ADORA2AADORA1ADORA3ADORA2BKDM4E
SCHEMBL3155892 0.86 ADORA2A (0.46) ADORA2AADORA1ADORA3ADORA2BKDM4E
SCHEMBL3257829 0.86 KDM4E (0.52) ADORA2AADORA1ADORA3KDM4EALDH1A1
SCHEMBL3171731 0.86 KDM4E (0.52) ADORA2AADORA1ADORA3KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback